199 related articles for article (PubMed ID: 24612675)
21. Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning.
Grigsby J; Brega AG; Bennett RE; Bourgeois JA; Seritan AL; Goodrich GK; Hagerman RJ
Clin Neuropsychol; 2016 Aug; 30(6):944-59. PubMed ID: 27355103
[TBL] [Abstract][Full Text] [Related]
22. Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele.
Rodriguez-Revenga L; Pagonabarraga J; Gómez-Anson B; López-Mourelo O; Izquierdo S; Alvarez-Mora MI; Granell E; Madrigal I; Milà M
Cerebellum; 2016 Oct; 15(5):570-7. PubMed ID: 27315125
[TBL] [Abstract][Full Text] [Related]
23. Enlarged perivascular spaces and their association with motor, cognition, MRI markers and cerebrovascular risk factors in male fragile X premutation carriers.
Elias-Mas A; Wang JY; Rodríguez-Revenga L; Kim K; Tassone F; Hessl D; Rivera SM; Hagerman R
J Neurol Sci; 2024 Jun; 461():123056. PubMed ID: 38772058
[TBL] [Abstract][Full Text] [Related]
24. Study of telomere length in men who carry a fragile X premutation or full mutation allele.
Albizua I; Chopra P; Allen EG; He W; Amin AS; Sherman SL
Hum Genet; 2020 Dec; 139(12):1531-1539. PubMed ID: 32533363
[TBL] [Abstract][Full Text] [Related]
25. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).
Greco CM; Berman RF; Martin RM; Tassone F; Schwartz PH; Chang A; Trapp BD; Iwahashi C; Brunberg J; Grigsby J; Hessl D; Becker EJ; Papazian J; Leehey MA; Hagerman RJ; Hagerman PJ
Brain; 2006 Jan; 129(Pt 1):243-55. PubMed ID: 16332642
[TBL] [Abstract][Full Text] [Related]
26. Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.
Pretto DI; Kumar M; Cao Z; Cunningham CL; Durbin-Johnson B; Qi L; Berman R; Noctor SC; Hagerman RJ; Pessah IN; Tassone F
Neurobiol Aging; 2014 May; 35(5):1189-97. PubMed ID: 24332449
[TBL] [Abstract][Full Text] [Related]
27. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.
Tassone F; Greco CM; Hunsaker MR; Seritan AL; Berman RF; Gane LW; Jacquemont S; Basuta K; Jin LW; Hagerman PJ; Hagerman RJ
Genes Brain Behav; 2012 Jul; 11(5):577-85. PubMed ID: 22463693
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictors of subjective memory complaints in adult male carriers of the FMR1 premutation.
Birch RC; Hocking DR; Trollor JN
Clin Neuropsychol; 2016 Aug; 30(6):834-48. PubMed ID: 27355815
[TBL] [Abstract][Full Text] [Related]
29. Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome.
Napoli E; Song G; Wong S; Hagerman R; Giulivi C
Cerebellum; 2016 Oct; 15(5):552-64. PubMed ID: 27089882
[TBL] [Abstract][Full Text] [Related]
30. A low symptomatic form of neurodegeneration in younger carriers of the FMR1 premutation, manifesting typical radiological changes.
Loesch DZ; Cook M; Litewka L; Gould E; Churchyard A; Tassone F; Slater HR; Storey E
J Med Genet; 2008 Mar; 45(3):179-81. PubMed ID: 18057083
[TBL] [Abstract][Full Text] [Related]
31. Methadone use in a male with the FMRI premutation and FXTAS.
Muzar Z; Lozano R; Schneider A; Adams PE; Faradz SM; Tassone F; Hagerman RJ
Am J Med Genet A; 2015 Jun; 167(6):1354-9. PubMed ID: 25900641
[TBL] [Abstract][Full Text] [Related]
32. Selective spatial processing deficits in an at-risk subgroup of the fragile X premutation.
Hocking DR; Kogan CS; Cornish KM
Brain Cogn; 2012 Jun; 79(1):39-44. PubMed ID: 22417865
[TBL] [Abstract][Full Text] [Related]
33. Amygdala dysfunction in men with the fragile X premutation.
Hessl D; Rivera S; Koldewyn K; Cordeiro L; Adams J; Tassone F; Hagerman PJ; Hagerman RJ
Brain; 2007 Feb; 130(Pt 2):404-16. PubMed ID: 17166860
[TBL] [Abstract][Full Text] [Related]
34. Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype?
Berry-Kravis E; Hall DA
Neurology; 2011 Aug; 77(7):612-3. PubMed ID: 21775737
[No Abstract] [Full Text] [Related]
35. Exploring inhibitory deficits in female premutation carriers of fragile X syndrome: through eye movements.
Shelton AL; Cornish K; Kraan C; Georgiou-Karistianis N; Metcalfe SA; Bradshaw JL; Hocking DR; Archibald AD; Cohen J; Trollor JN; Fielding J
Brain Cogn; 2014 Mar; 85():201-8. PubMed ID: 24424424
[TBL] [Abstract][Full Text] [Related]
36. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome.
Grigsby J; Brega AG; Engle K; Leehey MA; Hagerman RJ; Tassone F; Hessl D; Hagerman PJ; Cogswell JB; Bennett RE; Cook K; Hall DA; Bounds LS; Paulich MJ; Reynolds A
Neuropsychology; 2008 Jan; 22(1):48-60. PubMed ID: 18211155
[TBL] [Abstract][Full Text] [Related]
37. Skewed X Inactivation in Women Carrying the FMR1 Premutation and Its Relation with Fragile-X-Associated Tremor/Ataxia Syndrome.
Alvarez-Mora MI; Rodriguez-Revenga L; Feliu A; Badenas C; Madrigal I; Milà M
Neurodegener Dis; 2016; 16(3-4):290-2. PubMed ID: 26609701
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS).
Grigsby J; Leehey MA; Jacquemont S; Brunberg JA; Hagerman RJ; Wilson R; Epstein JH; Greco CM; Tassone F; Hagerman PJ
Cogn Behav Neurol; 2006 Sep; 19(3):165-71. PubMed ID: 16957495
[TBL] [Abstract][Full Text] [Related]
39. Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene.
Loesch DZ; Sherwell S; Kinsella G; Tassone F; Taylor A; Amor D; Sung S; Evans A
Clin Genet; 2012 Jul; 82(1):88-92. PubMed ID: 21476992
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
Allen EG; Hunter JE; Rusin M; Juncos J; Novak G; Hamilton D; Shubeck L; Charen K; Sherman SL
Neuropsychology; 2011 May; 25(3):404-411. PubMed ID: 21443343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
